Business ❯Market Competition

Pharmaceutical Industry

Drug Development Obesity Drug Market Eli Lilly vs Novo Nordisk Obesity Drugs Weight Loss Drugs Drug Competition Vaccine Manufacturers Generic Drugs Novo Nordisk

Pfizer Halts Development of Danuglipron After Liver Safety Concerns

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

Novo Nordisk's Amycretin Shows Promise as Next-Gen Weight Loss Drug